Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Burkhart

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry|March 22, 2005
Isoxazole ionotropic glutamate neurotransmittersDavid J Burkhart, N R Natale
Nature Materials|November 21, 2019
Softness makes it betterHerman F Staats, David J Burkhart
Nature Materials|January 24, 2018
Vaccine adjuvants: Softness makes it betterHerman F Staats, David J Burkhart
Journal of Nanobiotechnology|November 19, 2017
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccinesLuis O De Serrano, David J Burkhart
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2015
PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccinationHardeep S Oberoi, Yvonne M Yorgensen, Audrey Morasse, et al.
Journal of Medicinal Chemistry|November 24, 2005
Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNAGlen C Post, Benjamin L Barthel, David J Burkhart, et al.
Molecular Cancer Therapeutics|January 7, 2005
Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrinDavid J Burkhart, Brian T Kalet, Michael P Coleman, et al.
International Journal of Pharmaceutics|November 29, 2020
Co-adsorption of synthetic Mincle agonists and antigen to silica nanoparticles for enhanced vaccine activity: A formulation approach to co-deliveryWalid M Abdelwahab, Alexander Riffey, Cassie Buhl, et al.
Journal of Medicinal Chemistry|June 30, 2012
Synthesis and biological characterization of protease-activated prodrugs of doxazolidineBenjamin L Barthel, Daniel L Rudnicki, Thomas Price Kirby, et al.
Topics in Current Chemistry|April 23, 2013
Anthracycline-formaldehyde conjugates and their targeted prodrugsTad H Koch, Benjamin L Barthel, Brian T Kalet, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|March 22, 2005
Isoxazole ionotropic glutamate neurotransmittersDavid J Burkhart, N R Natale
Nature Materials|November 21, 2019
Softness makes it betterHerman F Staats, David J Burkhart
Nature Materials|January 24, 2018
Vaccine adjuvants: Softness makes it betterHerman F Staats, David J Burkhart
Journal of Nanobiotechnology|November 19, 2017
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccinesLuis O De Serrano, David J Burkhart
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2015
PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccinationHardeep S Oberoi, Yvonne M Yorgensen, Audrey Morasse, et al.
Journal of Medicinal Chemistry|November 24, 2005
Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNAGlen C Post, Benjamin L Barthel, David J Burkhart, et al.
Molecular Cancer Therapeutics|January 7, 2005
Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrinDavid J Burkhart, Brian T Kalet, Michael P Coleman, et al.
International Journal of Pharmaceutics|November 29, 2020
Co-adsorption of synthetic Mincle agonists and antigen to silica nanoparticles for enhanced vaccine activity: A formulation approach to co-deliveryWalid M Abdelwahab, Alexander Riffey, Cassie Buhl, et al.
Journal of Medicinal Chemistry|June 30, 2012
Synthesis and biological characterization of protease-activated prodrugs of doxazolidineBenjamin L Barthel, Daniel L Rudnicki, Thomas Price Kirby, et al.
Topics in Current Chemistry|April 23, 2013
Anthracycline-formaldehyde conjugates and their targeted prodrugsTad H Koch, Benjamin L Barthel, Brian T Kalet, et al.
Pageof 3